ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Genscript Biotech Corporation (PK)

Genscript Biotech Corporation (PK) (GNNSF)

1.50
0.00
(0.00%)
終了 7月13日 5:00AM

Genscript Biotech Corporation (PK) (GNNSF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
1.50
( - )
買値
1.50
売値
1.99
出来高
-
平均取引量 (3 か月)
US$ 18,050,761
財務取引量
-
0.00 日の範囲 0.00
1.30 52 週間の範囲 2.42
時価総額
企業価値
3.441B
前日終値
1.50
始値
-
時刻
最終取引時間
VWAP
-
歳入
959.53M
純利益
-532.83M
発行済株式数
2,188,137,343
浮動株比率 (%)
63.20%
機関投資家保有比率 (%)
16.97%
配当利回り
PER
-7.26
株価売上高倍率 (PSR)
4.07
1 株当たり利益 (EPS)
-0.25
ベータ
0.85

Genscript Biotech Corporation (PK) について

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through Life Science Services and Products;... Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products segments. The Life Science Services and Products segment provide research services and products which are used in fundamental to life-science research and application. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. It also offers SurePAGE, a precast gel series; CytoSinct, a Nanobeads product and services; and Benz-Neburase, a genetically engineered endonuclease. In addition, the company provides automated protein and antibody purification system; automated maxi-plasmid purification; automated mini-scale purification for plasmid, protein, and antibody; eBlot and eStain, a protein transfer and staining system; eZwest Lite, an automated western blotting device; CytoSinct, a cell isolation solution; pharmacokinetics and immunogenicity ELISA kits; COVID-19 detection cPass technology kits; and GenBox, a mini electrophoresis tank. It serves antibody drug discovery; gene therapy; vaccine; in vitro diagnostics; gene editing; plant biology; and synthetic biology solutions. The company was founded in 2002 and is headquartered in Wan Chai, Hong Kong. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
Wan Chai, Hong Kong
設立
2026
Genscript Biotech Corporation (PK) is listed in the sector of the その他OTC with ticker GNNSF. The last closing price for Genscript Biotech (PK) was US$1.50. Over the last year, Genscript Biotech (PK) shares have traded in a share price range of US$ 1.30 to US$ 2.42.

Genscript Biotech (PK) currently has 2,188,137,343 shares in issue. The market capitalisation of Genscript Biotech (PK) is US$3.28 billion. Genscript Biotech (PK) has a price to earnings ratio (PE ratio) of -7.26.

GNNSF 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1001.51.51.53001.5CS
4001.51.51.53001.5CS
120.085.63380281691.421.91.423041.66185876CS
26-0.34-18.47826086961.841.91.352941.56178431CS
52-0.17-10.17964071861.672.421.337491.75460354CS
156-0.65-30.23255813952.153.21.05145451.54921602CS
260-3.3-68.754.85.31.0590242.10105376CS

GNNSF - Frequently Asked Questions (FAQ)

What is the current Genscript Biotech Corporation (PK) share price?
The current share price of Genscript Biotech Corporation (PK) is US$ 1.50
How many Genscript Biotech Corporation (PK) shares are in issue?
Genscript Biotech Corporation (PK) has 2,188,137,343 shares in issue
What is the market cap of Genscript Biotech Corporation (PK)?
The market capitalisation of Genscript Biotech Corporation (PK) is USD 3.28B
What is the 1 year trading range for Genscript Biotech Corporation (PK) share price?
Genscript Biotech Corporation (PK) has traded in the range of US$ 1.30 to US$ 2.42 during the past year
What is the PE ratio of Genscript Biotech Corporation (PK)?
The price to earnings ratio of Genscript Biotech Corporation (PK) is -7.26
What is the cash to sales ratio of Genscript Biotech Corporation (PK)?
The cash to sales ratio of Genscript Biotech Corporation (PK) is 4.07
What is the registered address of Genscript Biotech Corporation (PK)?
The registered address for Genscript Biotech Corporation (PK) is Dah Sing Financial Centre, Wan Chai
What is the Genscript Biotech Corporation (PK) website address?
The website address for Genscript Biotech Corporation (PK) is www.genscript.com

GNNSF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock